Soluble Aβ Oligomers Formed Channels Leading to Calcium Dysregulation
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Mitochondrion-based organellar therapies for central nervous system diseases.
Zhao M, Wang J, Zhu S, Wang M, Chen C, Wang L Cell Commun Signal. 2024; 22(1):487.
PMID: 39390521 PMC: 11468137. DOI: 10.1186/s12964-024-01843-z.
References
1.
Parodi J, Ormeno D, Ochoa-de la Paz L
. Amyloid pore-channel hypothesis: effect of ethanol on aggregation state using frog oocytes for an Alzheimer's disease study. BMB Rep. 2014; 48(1):13-8.
PMC: 4345636.
DOI: 10.5483/bmbrep.2015.48.1.125.
View
2.
Viles J
. Imaging Amyloid-β Membrane Interactions: Ion-Channel Pores and Lipid-Bilayer Permeability in Alzheimer's Disease. Angew Chem Int Ed Engl. 2023; 62(25):e202215785.
PMC: 10953358.
DOI: 10.1002/anie.202215785.
View
3.
Popugaeva E, Chernyuk D, Bezprozvanny I
. Reversal of Calcium Dysregulation as Potential Approach for Treating Alzheimer's Disease. Curr Alzheimer Res. 2020; 17(4):344-354.
PMC: 8210816.
DOI: 10.2174/1567205017666200528162046.
View
4.
Cascella R, Cecchi C
. Calcium Dyshomeostasis in Alzheimer's Disease Pathogenesis. Int J Mol Sci. 2021; 22(9).
PMC: 8124842.
DOI: 10.3390/ijms22094914.
View
5.
Arispe N, Rojas E, Pollard H
. Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. Proc Natl Acad Sci U S A. 1993; 90(2):567-71.
PMC: 45704.
DOI: 10.1073/pnas.90.2.567.
View